Entry Notes
Release time:
2021-11-01
My son has been in kindergarten for almost a month in a twinkling of an eye. Except for the first day when he ran out of the classroom to find his mother, he insisted on going every day. Except for the lack of a smile on his face, everything went smoothly.
Children leave home for the first time, from the hair to the toes are worried. My son's kindergarten is less than one kilometer away from me, but I am highly nervous every day. It is obvious that the child was sent before going to work. I can pick up the child as soon as I get off work, but I am afraid of delaying a minute. During the day, I always think about his food, drink, pull, scatter and sleep, and worry about whether he has been bullied. Every day, I feel confused and see if the teacher has sent videos of children in the group.
children leave home for the first time, not only worried about the children, but also worried about whether they are qualified parents. I have poor language organization skills and want to ask the teacher about the child, but I am worried that the way I ask is wrong. One is that I cannot pay attention to the details of the child's life, and the other is that I am afraid of causing the teacher's disgust. I am a relatively independent person from an early age. I have been a resident student since the first grade. The school is 7 kilometers away from home, which 1. a senior student to take care of me in the second grade. Later, junior high school, Senior high school, and university became farther and farther away from home. Every time I went out to school, I packed my things by myself. Looking back, I never felt afraid. But now I find that because of love, children have missed many opportunities to learn independence and failed to teach this independence to children.
When I picked up my child from school on the first day, as soon as the teacher opened the classroom door, I found that her hair was wet with sweat. At that moment, I suddenly felt that I was worried too much. After that, every time I went to pick up the child, the teacher would tell us the child's performance, and even the teacher noticed what little tricks the son liked to do. I was relieved to know that the teachers are conscientious and it is not easy. I suddenly feel that my work is particularly good, facing adults who can be responsible for their own behavior, and the work content is relatively orderly, basically within the scope of their own abilities.
(Shang Yongzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31